Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, 6734667149, Iran.
Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, 6734667149, Iran.
Cancer Metastasis Rev. 2024 Mar;43(1):501-574. doi: 10.1007/s10555-023-10136-9. Epub 2023 Oct 4.
Tumor cells employ multiple signaling mediators to escape the hypoxic condition and trigger angiogenesis and metastasis. As a critical orchestrate of tumorigenic conditions, hypoxia-inducible factor-1 (HIF-1) is responsible for stimulating several target genes and dysregulated pathways in tumor invasion and migration. Therefore, targeting HIF-1 pathway and cross-talked mediators seems to be a novel strategy in cancer prevention and treatment. In recent decades, tremendous efforts have been made to develop multi-targeted therapies to modulate several dysregulated pathways in cancer angiogenesis, invasion, and metastasis. In this line, natural compounds have shown a bright future in combating angiogenic and metastatic conditions. Among the natural secondary metabolites, we have evaluated the critical potential of phenolic compounds, terpenes/terpenoids, alkaloids, sulfur compounds, marine- and microbe-derived agents in the attenuation of HIF-1, and interconnected pathways in fighting tumor-associated angiogenesis and invasion. This is the first comprehensive review on natural constituents as potential regulators of HIF-1 and interconnected pathways against cancer angiogenesis and metastasis. This review aims to reshape the previous strategies in cancer prevention and treatment.
肿瘤细胞利用多种信号介质来逃避缺氧环境,并触发血管生成和转移。作为肿瘤发生条件的关键协调者,缺氧诱导因子-1(HIF-1)负责刺激肿瘤侵袭和迁移中的几个靶基因和失调途径。因此,靶向 HIF-1 途径和相互作用的介质似乎是癌症预防和治疗的一种新策略。在过去的几十年中,人们做出了巨大的努力来开发多靶向治疗方法,以调节癌症血管生成、侵袭和转移中的几个失调途径。在这方面,天然化合物在对抗血管生成和转移性疾病方面显示出了光明的前景。在天然次级代谢产物中,我们评估了酚类化合物、萜类/萜烯、生物碱、含硫化合物、海洋和微生物来源的化合物在衰减 HIF-1 以及相互关联的途径方面的关键潜力,以对抗与肿瘤相关的血管生成和侵袭。这是第一篇关于天然成分作为 HIF-1 和相互关联的途径的潜在调节剂,以对抗癌症血管生成和转移的综合综述。本综述旨在重塑癌症预防和治疗的先前策略。
J Agric Food Chem. 2005-5-18
J Antibiot (Tokyo). 2021-10
Clin Cancer Res. 2007-10-1
Biomed Pharmacother. 2022-12
Ann Med Surg (Lond). 2025-7-18
Invest New Drugs. 2025-8-21
Biochem Pharmacol. 2022-5
Nutrients. 2022-2-13
Cancer Discov. 2022-1